Impact of heart failure unit complexity in the treatment with intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: Insights from the LEVO-D Registry
Por:
Dobarro, DD, Tobar, J, Sagasti, I, Rodriguez, M, Escolar, V, Abecia, A, Codina, P, Gomez-Otero, I, Pastor, F, Marzoa, R, Gonzalez-Babarro, E, De Juan-Baguda, J, Melendo-Viu, M, De Frutos, F and Gonzalez-Costello, J
Publicada:
1 jul 2022
Resumen:
Filiaciones:
Dobarro, DD:
Univ Hosp Complex Vigo, Vigo, Spain
Tobar, J:
Univ Hosp Clin Valladolid, Valladolid, Spain
Sagasti, I:
Hosp Cruces, Bilbao, Spain
Rodriguez, M:
Univ Assistance Complex Leon, Leon Hosp, Leon, Spain
Escolar, V:
Basurto Univ Hosp, Bilbao, Spain
Abecia, A:
Navarra Complex Hosp, Pamplona, Spain
:
Germans Trias & Pujol Hosp, Badalona, Spain
Gomez-Otero, I:
Univ Hosp Santiago De Compostela, Santiago De Compostela, Spain
Pastor, F:
Virgen Arrixaca Univ Hosp, Murcia, Spain
Marzoa, R:
Hosp Arquitecto Marice, Ferrol, Spain
Gonzalez-Babarro, E:
Montecelo Hosp Ctr, Pontevedra, Spain
De Juan-Baguda, J:
Univ Hosp 12 Octubre, Madrid, Spain
Melendo-Viu, M:
Univ Hosp Complex Vigo, Vigo, Spain
De Frutos, F:
Hosp Univ Puerta Hierro, Madrid, Spain
Gonzalez-Costello, J:
Univ Hosp Bellvitge, Lhospitalet De Llobregat, Spain
|